Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

47.46
BATS BZX Real-Time Price
As of 2:18pm ET
 +0.22 / +0.47%
Today’s Change
37.73
Today|||52-Week Range
50.39
-0.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$23.4B

Company Description

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company manages its operations in two geographic regional segments: the United States and International. Within each of these regions, it offers a diversified product portfolio, including vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceuticals, for both livestock and companion animal customers. Zoetis was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
100 Campus Drive
Florham Park New Jersey 07932
P:(973) 822-7000
Investor Relations:
(973) 822-7088

Employees

Shareholders

Other institutional50.10%
Mutual fund holders41.90%
Individual stakeholders25.82%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Kristin C. PeckExecutive Vice President & President-US Operations
Paul S. HerendeenChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Kate WaldenChief Compliance Officer